🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: AZD0530 may stop the growth of tumor cells by blocking some of t...
Status
Completed
Location
BCCA - Vancouver Cancer Centre
Start Date
2006-04-26
Trial ID
NCT00265876
Treatments Being Tested
Lymphangioleiomyomatosis (LAM) is a rare lung disease that mostly affects w...
Status
Completed
Location
University of Cincinnati
Start Date
2014-08
Trial ID
NCT02116712
Treatments Being Tested
Functional neuroimaging of alcoholism vulnerability: glutamate, reward, imp...
Status
Completed
Location
Hartford Hospital
Start Date
2014-11-01
Trial ID
NCT02262026
Treatments Being Tested
This phase II trial is studying how well saracatinib works in treating pati...
Status
Completed
Location
Hamilton Medical Center
Start Date
2008-01
Trial ID
NCT00607594
Treatments Being Tested
The aim of the study is to compare how different formulations of AZD0530 ar...
Status
Completed
Location
Research Site
Start Date
2008-11
Trial ID
NCT00771979
This is a dose escalation study to assess the safety and tolerability of AZ...
Status
Completed
Location
Research Site
Start Date
2008-06
Trial ID
NCT00704366
Treatments Being Tested
This phase II trial is studying how well AZD0530 works in treating patients...
Status
Completed
Location
City of Hope
Start Date
2007-08
Trial ID
NCT00513071
Treatments Being Tested
The main purpose of this study is to determine if AZD0530 can improve the e...
Status
Completed
Location
Research Site
Start Date
2008-04
Trial ID
NCT00610714
Treatments Being Tested
This phase II trial is studying how well saracatinib works in treating pati...
Status
Terminated
Location
Stanford University Hospitals and Clinics
Start Date
2008-06
Trial ID
NCT00718809
Treatments Being Tested
The purpose of the study is to determine if the maximum tolerated doses of ...
Status
Completed
Location
Research Site
Start Date
2007-05
Trial ID
NCT00475956